# Gameto

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gameto

- Industry: Biotechnology
- Headquarters: Austin, US
- Website: www.gametogen.com
- Total disclosed funding: $110M
- Latest round: Series C (Jul 21, 2025)
- Investors on record: 19

## About

Based in Texas, US, and founded in 2020, Gameto, Inc. operates as a biotechnology company that develops healthcare solutions for treating ovarian aging. As of 2022, the company is led by its CEO Dr. Dina Radenkovic. Gameto operates an ovarian therapies platform to address the problem of accelerated ovarian aging (granulosa cells & oocytes precursors) by producing human reprogrammed ovarian cells. As of 2022, the platform has three distinct programs: Fertilo, which aims to improve assisted fertility for women; Deovo, which is a first-in-class drug discovery and computational platform for ovarian aging; and Ameno, which aims to make menopause optional. The company plans to use the funding to accelerate the process to improve assisted fertility with reprogrammed ovarian cells. In July 2025, Gameto, Inc. raised USD 44 million in series C funding led by returning investor Overwater Ventures, with participation from other returning investors Insight Partners, RA Capital, Two Sigma Investments, BOLD Capital Partners, Future Ventures, Ingeborg Investments, Arcadia Investment Partners. New investors PagsGroup, Pontiva Healthcare Partners, Portfolia and other unspecified investors also participated in the round.

## Funding rounds

- Series C, Jul 21, 2025, $44M — Insight Partners, Two Sigma Investments, BOLD Capital Partners, Portfolia, Future Ventures, Overwater Ventures, Ingeborg Investments, Arcadia Investment Partners, Pontiva Healthcare Partners, PagsGroup, RA Capital
- Series B, May 20, 2024, $43M — Insight Partners, Two Sigma Investments, Lux Capital, TA Ventures, RA Capital Management, FJ Labs, BOLD Capital Partners, Plum Alley, Future Ventures, Yes VC, SALT Ventures, Myelin VC, Overwater Ventures, Ingeborg Investments, Arcadia Investment Partners
- Series A, Jan 11, 2022, $20M — Lux Capital, TA Ventures, BOLD Capital Partners, Plum Alley, Future Ventures, Overwater Ventures
- Seed, Apr 5, 2021 — FJ Labs
- Seed, Mar 1, 2020, $3M — FJ Labs, Salt Ventures

## Investors

- FJ Labs (https://capitalatlas.ai/funds/fj-labs) — Seed, Series B
- Salt Ventures — Seed, Series B
- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Series A, Series B
- TA Ventures (https://capitalatlas.ai/funds/ta-ventures) — Series A, Series B
- BOLD Capital Partners (https://capitalatlas.ai/funds/bold-capital-partners) — Series A, Series B, Series C
- Plum Alley (https://capitalatlas.ai/funds/plum-alley) — Series A, Series B
- Future Ventures — Series A, Series B, Series C
- Overwater Ventures (https://capitalatlas.ai/funds/overwater-ventures) — Series A, Series B, Series C
- Insight Partners (https://capitalatlas.ai/funds/insight-partners) — Series B, Series C
- Two Sigma Investments (https://capitalatlas.ai/funds/two-sigma-investments) — Series B, Series C
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series B
- Yes VC (https://capitalatlas.ai/funds/yes-vc) — Series B
- Myelin VC (https://capitalatlas.ai/funds/myelin-vc) — Series B
- Ingeborg Investments (https://capitalatlas.ai/funds/ingeborg-investments) — Series B, Series C
- Arcadia Investment Partners — Series B, Series C
- Portfolia (https://capitalatlas.ai/funds/portfolia) — Series C
- Pontiva Healthcare Partners (https://capitalatlas.ai/funds/pontiva-healthcare-partners) — Series C
- PagsGroup — Series C
- RA Capital — Series C